Actinogen anticipates final topline efficacy and safety results for the full 36-week treatment period in November 2026.

Vitamin D may be a potentially modifiable factor to reduce dementia risk, study suggests ...

A proprietary monoclonal antibody targeting an inhibitory immune checkpoint pathway had favorable safety and tolerability in ...

For the millions of people who carry the gene APOE4, the strongest known genetic risk factor for Alzheimer's disease, their ...

In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...

Scientists may have sniffed out a breakthrough when detecting Alzheimer’s. The degenerative disease, which affects millions ...

New research has found that eating more meat could help prevent Alzheimer's in some people who carry a gene that heightens ...

A simple nasal swab may offer an unexpected window into the earliest biological signals of Alzheimer’s disease.

Campbell: Welcome to "Beyond Diagnosis," where we talk with doctors about talking with patients. I'm your host, Glenn ...

The National Institutes of Health has renewed support for Artificial Intelligence for Alzheimer’s Disease, or AI4AD. The new ...

After seeing the impact Alzheimer’s has on families, a Lansing nursing student is now raising awareness about brain health ...